SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-104629
Filing Date
2020-09-14
Accepted
2020-09-14 08:42:56
Documents
43
Period of Report
2020-09-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2030482-1_8k.htm   iXBRL 8-K 30796
2 EXHIBIT 99.1 tm2030482d1_ex99-1.htm EX-99.1 14430
3 EXHIBIT 99.2 tm2030482d1_ex99-2.htm EX-99.2 47710
7 GRAPHIC tm2030482d1_ex99-1img001.jpg GRAPHIC 5165
8 GRAPHIC tm2030482d1_ex99-2img001.jpg GRAPHIC 228950
9 GRAPHIC tm2030482d1_ex99-2img002.jpg GRAPHIC 227088
10 GRAPHIC tm2030482d1_ex99-2img003.jpg GRAPHIC 143276
11 GRAPHIC tm2030482d1_ex99-2img004.jpg GRAPHIC 160810
12 GRAPHIC tm2030482d1_ex99-2img005.jpg GRAPHIC 110707
13 GRAPHIC tm2030482d1_ex99-2img006.jpg GRAPHIC 136823
14 GRAPHIC tm2030482d1_ex99-2img007.jpg GRAPHIC 266771
15 GRAPHIC tm2030482d1_ex99-2img008.jpg GRAPHIC 137969
16 GRAPHIC tm2030482d1_ex99-2img009.jpg GRAPHIC 195393
17 GRAPHIC tm2030482d1_ex99-2img010.jpg GRAPHIC 117901
18 GRAPHIC tm2030482d1_ex99-2img011.jpg GRAPHIC 104680
19 GRAPHIC tm2030482d1_ex99-2img012.jpg GRAPHIC 130171
20 GRAPHIC tm2030482d1_ex99-2img013.jpg GRAPHIC 112984
21 GRAPHIC tm2030482d1_ex99-2img014.jpg GRAPHIC 226761
22 GRAPHIC tm2030482d1_ex99-2img015.jpg GRAPHIC 210805
23 GRAPHIC tm2030482d1_ex99-2img016.jpg GRAPHIC 134104
24 GRAPHIC tm2030482d1_ex99-2img017.jpg GRAPHIC 130796
25 GRAPHIC tm2030482d1_ex99-2img018.jpg GRAPHIC 157815
26 GRAPHIC tm2030482d1_ex99-2img019.jpg GRAPHIC 120014
27 GRAPHIC tm2030482d1_ex99-2img020.jpg GRAPHIC 247664
28 GRAPHIC tm2030482d1_ex99-2img021.jpg GRAPHIC 127975
29 GRAPHIC tm2030482d1_ex99-2img022.jpg GRAPHIC 184919
30 GRAPHIC tm2030482d1_ex99-2img023.jpg GRAPHIC 169408
31 GRAPHIC tm2030482d1_ex99-2img024.jpg GRAPHIC 137328
32 GRAPHIC tm2030482d1_ex99-2img025.jpg GRAPHIC 177286
33 GRAPHIC tm2030482d1_ex99-2img026.jpg GRAPHIC 205047
34 GRAPHIC tm2030482d1_ex99-2img027.jpg GRAPHIC 200501
35 GRAPHIC tm2030482d1_ex99-2img028.jpg GRAPHIC 228950
  Complete submission text file 0001104659-20-104629.txt   6821998

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mnlo-20200908.xsd EX-101.SCH 3213
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnlo-20200908_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnlo-20200908_pre.xml EX-101.PRE 22728
36 EXTRACTED XBRL INSTANCE DOCUMENT tm2030482-1_8k_htm.xml XML 3712
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 201172376
SIC: 2834 Pharmaceutical Preparations